Autumn Starnes, DO
Dermatology · Wise, VANPI 1063605228
Payments from drug & device makers
Across 244 payments — averaging $50.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$7K
- Johnson & Johnson$2K
- Novartis$934
- AbbVie$602
- Sun Pharmaceutical Industries Inc.$494
- Sanofi$226
- plus $1K from 15 others
What the payments were for
- Speaking & faculty fees$5,90048%
- Travel & lodging$8307%
- Food & beverage$5,24942%
- Education$4123%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 29 | $7,306 |
| Johnson & Johnson | 71 | $1,662 |
| Novartis | 47 | $934 |
| AbbVie | 20 | $602 |
| Sun Pharmaceutical Industries Inc. | 23 | $494 |
| Sanofi | 6 | $226 |
| Revance Therapeutics, Inc. | 2 | $195 |
| Regeneron Healthcare Solutions, Inc. | 7 | $164 |
| E.r. Squibb & Sons, L.L.C. | 7 | $142 |
| Arcutis Biotherapeutics, Inc. | 7 | $142 |
| Lilly USA, LLC | 6 | $108 |
| Amgen | 4 | $89 |
| Incyte Corporation | 3 | $61 |
| Organon | 2 | $50 |
| Janssen Scientific Affairs, LLC | 1 | $47 |
| Boehringer Ingelheim | 2 | $44 |
| Galderma Laboratories, L.p. | 2 | $39 |
| Dermavant Sciences, Inc. | 2 | $34 |
| Biofrontera Inc. | 1 | $22 |
| Sandoz | 1 | $18 |
| Genentech USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,391 in reported general payments places this provider in the 80th percentile of 396 dermatology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Unoready PenSecukinumab | 16 | $181,386 |
| Dupixent PenDupilumab | 29 | $114,579 |
| Enbrel SureclickEtanercept | 11 | $80,327 |
| Dupixent SyringeDupilumab | 16 | $69,705 |
| Clobetasol Propionate | 169 | $7,615 |
| Ketoconazole | 281 | $4,501 |
| Metronidazole | 48 | $1,944 |
| Ammonium Lactate | 54 | $1,543 |
| Hydrocortisone | 70 | $1,262 |
| Ciclopirox | 28 | $1,236 |
| Triamcinolone Acetonide | 97 | $1,208 |
| Clindamycin Phosphate | 27 | $860 |
| Mometasone Furoate | 40 | $837 |
| Fluorouracil | 11 | $640 |
| Permethrin | 12 | $497 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Wise
- David PariserNorfolk$7M
- Jennifer DesimoneFairfax$2.3M
- Naiem IssaVienna$2M
- Saurabh SinghFairfax$1.7M
- Vishal PatelLeesburg$1.1M
- Diego DasilvaVirginia Beach$1.1M
- Carrie CobbLynchburg$859K
- Yvonne KnightRichmond$857K
- David BrayAlexandria$799K
- Cyndi Torosky TommasoVirginia Beach$717K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.